MedTrace Logo

Safety and Efficacy of EZ-Ject Injector a Pain-Free Subcutaneous Automatic Injection in Healthy Volunteers

NCT00684333 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2009-01-14

No results posted yet for this study

Summary

Subcutaneous injections are a widely used method for drug delivery. One of its major drawbacks is the pain inflicted during the process. Sindolor has developed the chemical-free EZ-Ject Injector device, based on employing cutaneous local anesthesia on the injection site by an electronic anesthetic system. The purpose of this study is to determine the safety and efficacy of the EZ-Ject for subcutaneous injections.

Conditions

  • Healthy

Interventions

DEVICE

painless subcutaneous injection by EZ-Ject Injector

EZ-Ject Injector device employee cutaneous local anesthesia on the injection site by an electronic anesthetic system

Sponsors & Collaborators

  • Sindolor

    lead INDUSTRY

Principal Investigators

  • Jacob Atsmon, M.D. · Ichilov Medical center

Study Design

Allocation
NA
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00684333 on ClinicalTrials.gov